KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Receivables (2016 - 2025)

Teladoc Health (TDOC) has disclosed Receivables for 12 consecutive years, with $201.7 million as the latest value for Q4 2025.

  • Quarterly Receivables fell 9.96% to $201.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $201.7 million through Dec 2025, down 9.96% year-over-year, with the annual reading at $201.7 million for FY2025, 9.96% down from the prior year.
  • Receivables hit $201.7 million in Q4 2025 for Teladoc Health, down from $219.5 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $243.2 million in Q1 2025 to a low of $178.1 million in Q3 2021.
  • Historically, Receivables has averaged $217.5 million across 5 years, with a median of $225.1 million in 2022.
  • Biggest five-year swings in Receivables: skyrocketed 152.18% in 2021 and later dropped 9.96% in 2025.
  • Year by year, Receivables stood at $190.1 million in 2021, then grew by 23.94% to $235.6 million in 2022, then decreased by 2.37% to $230.1 million in 2023, then decreased by 2.65% to $224.0 million in 2024, then decreased by 9.96% to $201.7 million in 2025.
  • Business Quant data shows Receivables for TDOC at $201.7 million in Q4 2025, $219.5 million in Q3 2025, and $234.0 million in Q2 2025.